Rate My Professor bruce taylor

Professor Bruce Taylor serves as Professor of Neurological Research at the Menzies Institute for Medical Research, part of the College of Health and Medicine at the University of Tasmania. A medical graduate from the University of Tasmania, he completed specialist neurology training and practices as a clinical neurologist while leading a prominent research program on multiple sclerosis (MS). As Academic Lead of the MS Research Flagship, his group investigates MS epidemiology, genetic risk factors, disease progression biomarkers, clinical trial design, symptom management, and health economics. Notable contributions include demonstrating latitude's strong association with MS prevalence via meta-analysis, identifying the first genetic marker predicting MS severity, establishing that menopause does not worsen MS disability, and quantifying Australia's MS prevalence and $3 billion annual economic burden.

Taylor's scholarly impact is evidenced by over 40,000 citations and an h-index of 84 on Google Scholar. Key publications encompass 'Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis' (2011, Journal of Neurology, Neurosurgery & Psychiatry), 'Predictors of progression from a first demyelinating event to multiple sclerosis' (2022, Brain Communications), 'Menopause does not worsen MS disability, landmark study finds' (2025), and 'New report reveals $3 billion annual cost of MS in Australia' (2025). He holds an NHMRC Investigator Grant (2009389), leads a $3 million Centre of Research Excellence in MS, and co-chairs international workshops on MS prevention. Awards include Fellowship of the Australian Academy of Health and Medical Sciences (2022) and co-recipient of the 2025 MS Research Australia Award. Taylor supervises doctoral students, contributes to clinical trials like TAURUS on brain stimulation for MS fatigue, and engages in public education and policy through MS Australia reports.